Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors
Estrogen receptor (ER)-positive progesterone receptor (PR)-negative breast cancers are infrequent but clinically challenging. Despite the volume of genomic data available on these tumors, their biology remains poorly understood. Here, we aimed to identify clinically relevant subclasses of ER+/PR&...
Main Authors: | Gianluca Lopez, Jole Costanza, Matteo Colleoni, Laura Fontana, Stefano Ferrero, Monica Miozzo, Nicola Fusco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/3/510 |
Similar Items
-
Prognostic Impact of Low Estrogen and Progesterone Positivity in Luminal B (HER2 Negative) Breast Cancer
by: Jasmina Rajc, et al.
Published: (2018-01-01) -
Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms
by: Ping Zhang, et al.
Published: (2023-04-01) -
The effect of aerobic exercise and pomegranate juice consumption on serum levels of estrogen, progesterone and P53 protein in women with breast cancer
by: Mohsen Akbarpour, et al.
Published: (2021-05-01) -
To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma
by: Anuja Yadav, et al.
Published: (2024-01-01) -
High Mutation Burden in ER-Positive/HER2-Negative/Luminal Breast Cancers
by: Ioannis A. Voutsadakis
Published: (2022-03-01)